Summary
The present study was undertaken to investigate to what extent the oestrogen-induced effects on growth and morphology of the Dunning R3327 rat prostatic adenocarcinoma are dose-dependent. Castrated and testosterone-supplemented rats were used in order to study effects of increasing doses of oestrogens on the tumour. It was found that the lowest dose of oestradiol-17β that reduced the overall growth, the volume density of the epithelium and epithelial cell area in Dunning R3327 prostatic tumours is 10 μg given as daily injections. Higher oestrogen doses (50 μg, 200 μg, and 500 μg), in addition to reducing the volume of tumour epithelium, also induced an increase of the volume density of tumour stroma. The area of stroma cell nuclei was increased by 50 μg and 200 μg oestradiol-17β. These observation, may indicate that the lowest effective oestrogen dose is different in the epithelium and stroma of Dunning tumours and that large doses of oestrogen stimulate the stromal compartment. This stimulatory effect did not influence the inhibitory effects seen on the overall growth of the tumour and on the tumor epithelium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Citrin DL, Merrill KS, Wallemark C-B, Khandekar J, Kaplan E, Camacho F, Lind R (1985) A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostatic cancer. Cancer 56:457–460
Cunha GR, Lung B (1979) Importance of stroma in morphogenesis and functional activity of urogenital epithelium. In vitro 15:50–71
Cunha GR, Reese BA, Sekkingstad M (1980) Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice. Endocrinology 107:1767–1770
Daehlin L, Damber J-E (1986) Blood flow in the Dunning R3327H rat prostatic carcinoma; effects of oestradiol and testosterone. Urol Res 14:113–117
Daehlin L, Bergh A, Damber J-E (1987) Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma. Urol Res 15:169–172
Dunning W (1963) Prostate cancer in the rat. Natl Cancer Inst Monogr 12:351–369
Fujji H, Cunha GR, Norman JT (1982) The induction of adenocarcinomatous differentiation in neoplastic bladder embryonic epithelium by an prostatic inductor. J Urol 128:858
Harper ME, Peeling WB, Cowley T, Brownsey BG, Phillips MEA, Groom G, Fahmy DR, Griffiths K (1976) Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol (Kbh) 81:409–426
Ip MM, Milholland RJ, Rosen F (1980) Functionality of estrogen receptor and tamoxifen treatment of Dunning R3327 Dunning rat prostate adenocarcinoma. Cancer Res 40:2188–2193
Isaacs JT (1984) The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. Prostate 5:1–17
Isaacs JT (1987) Development and characteristics of the available animal model systems for the study of prostatic cancer. Prog Clin Biol Res 239:513–566
Janik P, Briand, Hartmann NR (1975) The effect of estrogen-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumours. Cancer Res 35:3698–3704
Landström M, Tomic R, Damber J-E (1987) Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma. Eur Urol 13:203–206
Landström M, Damber J-E, Bergh A, Tomic R, Carlsson-Bostedt L, Stigbrand T (1988) Antiestrogens do not counteract the inhibitory effect of estradiol-17β on the growth of the Dunning R3327 prostatic adenocarcinoma. Prostate 12:287–298
Landström M, Bergh A, Tomic R, Damber J-E (1990) Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate 17:57–68
Mawhinney MG, Neubauer BL (1979) Actions of estrogen in the male. Invest Urol 16:409–420
Mobbs BG, Johnson IE (1985) Characterization of estrogen-induced progestin binding in cytosol of R3327H prostatic carcinoma of the rat. J Steroid Biochem 22:57–62
Owens AH, Coffey DS, Baylin SB (1982) Tumor cell heterogenity. Origins and implications. J Iowa Med Soc 49:1096–1098
Rolf PL, Flocks RH (1969) Stilphostrol therapy in 100 cases of prostatic carcinoma. Journal of Iowa Medical Society, Vol LIX, No 12, 1096–1098, December
Sandberg AA (1980) Endocrine control and physiology of the prostate. Prostate 1:169–184
Schneider MR, Schönenberger H (1988) Effects of diethylstilbestrol and its mono- and diphosphate on experimental mammary and prostatic tumours. Urol Int 43 [Suppl 1]:10–14
Schneider MR; Humm A, Graf AH (1990) The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat. J Cancer Res Clin Oncol 116:159–167
Schulz P, Lepier A, Bauer HW, Brade W, Keller A, Fittler F (1987) Experimental evidence of a direct cytotoxic effect of diethylstilbestrol diphosphate on prostatic carcinoma cells at concentrations attained during therapeutical infusions. Abstr J Steroid Biochem [Suppl] 28:81
Schulz P, Vetter I, Bauer HW, Fittler F (1988) Evaluation of the cytotoxic activity of diethylstilbestrol and its phosphorylated derivates towards prostatic carcinoma, non-prostatic neoplastic and non-transformed cells. Urol Int 43 [Suppl 1]:5–9
Siegel S (1956) Non-parametric statistics for the behavioural sciences. McGraw-Hill Kogakusha, Tokyo
Susan PL, Roth RB, Adkins WC (1976) Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate. Urology 7:598–601
van Steenbrugge GJ, Groen M, van Kreuningen A, de Jong FH, Gallee MPW, Schröder FH (1988) Transplantable human prostatic carcinoma (PC-82) in atypic nude mice. III. Effects of estrogens on the growth of tumor tissue. Prostate 12:157–171
Walsh PC (1975) Physiologic basis for hormonal therapy in carcinoma of the prostate. Urol Clin North Am 2:125–140
Weibel ER (1979) Sterological methods, vol 1. Practical methods for biological morphometry. Academic Press, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landström, M., Damber, J.E., Bergh, A. et al. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma. J Cancer Res Clin Oncol 118, 30–34 (1992). https://doi.org/10.1007/BF01192308
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01192308